BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
Portfolio Pulse from
BD (Becton, Dickinson and Company) and Biosero have announced a collaboration to integrate robotic arms with BD's flow cytometry instruments, aiming to accelerate drug discovery and development.
January 23, 2025 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BD has partnered with Biosero to integrate robotic arms with its flow cytometry instruments, which could enhance drug discovery and development processes.
The collaboration with Biosero to integrate robotic arms with BD's flow cytometry instruments is likely to enhance the efficiency and speed of drug discovery and development. This could lead to increased demand for BD's products, positively impacting its stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90